This post is opinion of the author...
NOVEMBER 28th 2019
Well over 4 months now...
So any day now...
Dr Silvia Pfeiffer, CEO and co-founder of Coviu added, “At Coviu we are committed to providing the best software for video visits so that doctors can bring the same level of outstanding care that they provide in face-to-face consultations to online consultations.
We look forward to being able to provide ResApp’s respiratory diagnostic solutions as a tool for clinicians who use our platform to accurately diagnose and care for patients with respiratory conditions.”
Coviu and ResApp will work together under a joint development agreement
From November 29th 2019...
for the next four months to integrate ResAppDx-EU into Coviu’s browser-based telehealth platform,
to devise a workflow for directing patients and clinicians towards the use of ResAppDx-EU in appropriate circumstances and to prepare a list of actions for clinicians to take after reviewing the test results. Before the conclusion of the project, ResApp and Coviu will enter into negotiations on the cost model of using ResAppDx-EU on the Coviu platform within Australia.
I am so....... looking forward to hearing more on Corviu deal...
Corviu doing over 25,000 telehealth visits a day...
TK esitmating on conference calls that around 50% are respiratory related...
And...this
further again from press release from Corviu...
"We look forward to being able to provide ResApp’s respiratory diagnostic solutions as a tool for clinicians who use our platform to accurately diagnose and care for patients with respiratory conditions.”
I the author, expect all clinicians conducting a respiratory consultation on the Corviu platform will use Resapp dx EU
Why would the Dr's guess a respiratory diagnosis when they have a government approved respiratory diagnostic tool at their finger tips...
In my opinion not using Resapp dx EU when it is avaiable may be even neglegent of care provision during a telehealth consultation...
This is why I expect 100% up take on for use of Resapp dx EU TGA approved in all or 90% of respiratory consultations on both Phenix and Corviu telehealth platforms.
Doctor friends of mine agree with me 100% on my opinion...
I am so excited...
T minus 8 trading days to live on Phenix...
MB
Ann: ResAppDx-EU to be deployed on the Coviu Telehealth Platform, page-123
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #